Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07725237) titled 'SPECT/CT Prospective Double-Scanning Study' on July 21.
Study Type: Observational
Primary Sponsor: GE Healthcare
Condition:
SPECT-CT
Intervention:
Device: StarGuide GX SPECT/CT Scan
Recruitment Status: Not recruiting
Date of First Enrollment: June 2026
Target Sample Size: 30
Countries of Recruitment:
Israel
To know more, visit https://clinicaltrials.gov/study/NCT07725237
Disclaimer: Curated by HT Syndication....